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Kidney lesions may be difficult to diagnose only by radiological exams, often requiring proof by tissue biopsy. Moreover, if enlarged
regional lymph nodes are also present, the spectrum of differential diagnoses is even greater. The role of regional lymph node
dissection in this setting is not clearly established. We show the case of a patient with a kidney mass associated with a conglomerate
of para-aortic and iliac lymphadenopathies corresponding to an oncocytoma and a nodular lymphocyte predominant Hodgkin’
lymphoma, respectively. Diagnosis of these two lesions was performed by morphology and immunohistochemistry. This case
reflects how imaging can mislead to diagnosis and how histological confirmation helps decide treatment management.
1. Introduction
Renal oncocytomas are uncommon benign neoplasms of the
urinary tract, accounting for 3% to 9% of all renal tumors [1].
Most cases are found incidentally by radiological exams, as
they are indolent and mostly asymptomatic. Distinguishing
an oncocytoma from amalignant tumor only by imaging can
be challenging. Biopsy remains the mainstay of diagnosis.
Having tissue proven diagnosis permits, depending on tumor
size, to choose active surveillance over surgical interventions
and to preserve kidney function. There is no sufficient evi-
dence in the literature on whether lymph node dissection
should be done whenever a suspected kidney lesion is found.
2. Case Report
A76-year-oldwomanwith no significant pastmedical history
was admitted because of a new rapid atrial fibrillation and
congestive heart failure due to an underlying coronary heart
disease. A computed tomography (CT) was requested to rule
out pulmonary embolism. Incidentally, a large left kidney
mass was discovered. The CT showed the 9 cm diameter
lesion localized in the midregion of the left kidney, with
central areas of low attenuation and a conglomerate of left
para-aortic and iliac lymphadenopathies (Figure 1). No other
distant lesion was seen.
The patient did not report any pain, weight loss, B
symptoms, or haematuria. On physical examination, bibasal
rales and bipedal pitting edema were noted. No red blood
cells were found in the urinalysis. The hemoglobin, serum
creatinine, and urea were also normal.
Amalignant kidney tumorwas suspected.Thepatientwas
addressed at our oncology department to discuss treatment.
Because of the bulky lymphadenopathies, the urological
surgeon did inquire about the role of neoadjuvant treat-
ment. Considering the lack of histological diagnosis and the
underlying heart disease, no indication for targeted treatment
was retained, and a surgical resection was proposed. A
total left nephrectomy with para-aortic lymphadenectomy
by median laparotomy was performed. The anatomopatho-
logical report revealed a 8 × 8 × 7 cm tan-brown nonen-
capsulated tumor in the left kidney with central fibrosis.
Histologically, well-differentiated neoplastic cells were seen
with abundant eosinophilic granular cytoplasm, compatible
with oncocytoma. The multiple para-aortic lymph nodes
showed a nodular growth pattern and a background of
lymphohistiocytes with a phenotype B CD20+. Comple-
mentary immunohistochemistry exams confirmed a nodular
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Figure 1: Left kidney lesion with left para-aortic lymphadeno-
pathies.
lymphocyte predominant Hodgkin’ lymphoma (NLPHL).
The staging evaluation concluded to a stage IIA for the
NLPHL, and the oncocytoma showed no distant metastasis.
Only clinical and radiologic followup was proposed.
3. Discussion
In our case, the initial radiological interpretation of the renal
oncocytoma was challenging. Morphological characteristics
were typical for renal cell carcinoma (RCC) as well, leading
to prioritize a surgical resection for what was thought to
be a malignant lesion. As retroperitoneal lymph nodes were
voluminously present, a sampling lymphadenectomywas also
performed. The anatomopathological report revealed two
unexpected diagnoses.
There is no clear data in the literature concerning benefit
of lymph node dissection in RCC. It is well known that the
survival of patients with regional lymph node metastasis is
similar to that of patients with distant metastatic lesions [2].
Thus, it is important to make a good staging of the disease
in order to choose the best therapeutic approach. There is
only one prospective randomized trial showing that lymph
node dissection in clinical N0 cases has minimal benefit:
Blom et al. randomized 772 patients between nephrectomy
alone and nephrectomy with lymph node dissection. The
rate of node positivity was low (4%), and no survival benefit
was shown [3]. However, when lymph node metastasis is
suspected, lymphadenectomy should be considered. Pantuck
et al. reported in a retrospective study with 900 RCC patients
treated surgically that, in node positive cases, lymphadenec-
tomy was associated with improved survival and, moreover,
with better response to immunotherapy.
This case illustrates how alone imaging can bemisleading.
A biopsy could have been performed, but that would not
have avoided the nephrectomy, as the kidney lesion was
voluminous. Lymph node resection permitted to diagnose
a lymphoma instead of a metastatic state of the presumably
RCC, changing completely the treatment approach. Lymph
node dissection was indicated in this situation, because
it revealed crucial diagnostic information. No oncologic
treatment should be delivered based on assumptions without
histological confirmation. Assessments in amultidisciplinary
meeting including a medical oncologist, a urologist, and a
radiologist can help to avoid regrettable pitfalls.
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